Binding of human proteins to amyloid-β protofibrils

ACS Chemical Biology

Volumn 10, Issue 3, 2015, Pages 766-774

  Rahman, M Mahafuzur ^a   Zetterberg, Henrik ^b,c   Lendel, Christofer ^a   Hard, Torleif ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; PLASMA PROTEIN; PROTEIN AGGREGATE; PROTEIN BINDING; PROTEIN CEREBROSPINAL FLUID LEVEL; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPLEMENT SYSTEM; CYTOTOXICITY; FEMALE; HEMOSTASIS; HUMAN; LIPID METABOLISM; LIPID TRANSPORT; MALE; MIDDLE AGED; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DEGRADATION; SERUM; SURFACE PLASMON RESONANCE; ALZHEIMER DISEASE; CHEMISTRY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN ENGINEERING;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; BLOOD PROTEINS; CEREBROSPINAL FLUID PROTEINS; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HUMANS; KINETICS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN AGGREGATES; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN INTERACTION MAPPING; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE;

EID: 84925355903     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb5008663     Document Type: Article

References (44)

1. Hardy, J. A. and Higgins, G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis Science 256, 184-185
2. Walsh, D. M. and Selkoe, D. J. (2007) Aβ oligomers-a decade of discovery J. Neurochem. 101, 1172-1184
3. Olzscha, H., Schermann, S. M., Woerner, A. C., Pinkert, S., Hecht, M. H., Tartaglia, G. G., Vendruscolo, M., Hayer-Hartl, M., Hartl, F. U., and Vabulas, R. M. (2011) Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions Cell 144, 67-78
4. Liao, L., Cheng, D., Wang, J., Duong, D. M., Losik, T. G., Gearingaaa, M., Rees, H. D., Lah, J. J., Levey, A. I., and Peng, J. (2004) Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection J. Biol. Chem. 279, 37061-37068
5. McGeer, P. L., Klegeris, A., Walker, D. G., Yasuhara, O., and McGeer, E. G. (1994) Pathological proteins in senile plaques Tohoku J. Exp. Med. 174, 269-277
6. Cedervall, T., Lynch, I., Foy, M., Berggard, T., Donnelly, S. C., Cagney, G., Linse, S., and Dawson, K. A. (2007) Detailed identification of plasma proteins adsorbed on copolymer nanoparticles Angew. Chem., Int. Ed. Engl. 46, 5754-5756
7. Lynch, I., Cedervall, T., Lundqvist, M., Cabaleiro-Lago, C., Linse, S., and Dawson, K. A. (2007) The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century Adv. Colloid Interface Sci. 134-135, 167-174
8. Sandberg, A., Luheshi, L. M., Sollvander, S., Pereira de Barros, T., Macao, B., Knowles, T. P., Biverstal, H., Lendel, C., Ekholm-Petterson, F., Dubnovitsky, A., Lannfelt, L., Dobson, C. M., and Hard, T. (2010) Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering Proc. Natl. Acad. Sci. U. S. A. 107, 15595-15600
9. Dubnovitsky, A., Sandberg, A., Rahman, M. M., Benilova, I., Lendel, C., and Hard, T. (2013) Amyloid-β protofibrils: size, morphology and synaptotoxicity of an engineered mimic PLoS One 8, e66101
10. Lendel, C., Bjerring, M., Dubnovitsky, A., Kelly, R. T., Filippov, A., Antzutkin, O. N., Nielsen, N. C., and Hard, T. (2014) A hexameric peptide barrel as building block of amyloid-β Protofibrils Angew. Chem., Int. Ed. Engl. 53, 12756-12760
11. Sanders, S. L., Jennings, J., Canutescu, A., Link, A. J., and Weil, P. A. (2002) Proteomics of the eukaryotic transcription machinery: identification of proteins associated with components of yeast TFIID by multidimensional mass spectrometry Mol. Cell. Biol. 22, 4723-4738
12. Blennow, K., Hampel, H., Weiner, M., and Zetterberg, H. (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat. Rev. Neurol. 6, 131-144
13. Calero, M., Rostagno, A., and Ghiso, J. (2012) Search for amyloid-binding proteins by affinity chromatography Methods Mol. Biol. 849, 213-223
14. Aksenov, M. Y., Aksenova, M. V., Carney, J. M., and Butterfield, D. A. (1996) Alpha 1-antichymotrypsin interaction with Aβ(1-42) does not inhibit fibril formation but attenuates the peptide toxicity Neurosci. Lett. 217, 117-120
15. Drouet, B., Fifre, A., Pincon-Raymond, M., Vandekerckhove, J., Rosseneu, M., Gueant, J. L., Chambaz, J., and Pillot, T. (2001) ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-β peptide J. Neurochem. 76, 117-127
16. Paula-Lima, A. C., Tricerri, M. A., Brito-Moreira, J., Bomfim, T. R., Oliveira, F. F., Magdesian, M. H., Grinberg, L. T., Panizzutti, R., and Ferreira, S. T. (2009) Human apolipoprotein A-I binds amyloid-β and prevents Aβ-induced neurotoxicity Int. J. Biochem. Cell Biol. 41, 1361-1370
17. Pisalyaput, K. and Tenner, A. J. (2008) Complement component C1q inhibits β-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms J. Neurochem. 104, 696-707
18. Yerbury, J. J., Poon, S., Meehan, S., Thompson, B., Kumita, J. R., Dobson, C. M., and Wilson, M. R. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures FASEB J. 21, 2312-2322
19. Cerf, E., Gustot, A., Goormaghtigh, E., Ruysschaert, J. M., and Raussens, V. (2011) High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease FASEB J. 25, 1585-1595
20. DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., Harmony, J. A., Aronow, B. J., Bales, K. R., Paul, S. M., and Holtzman, D. M. (2004) ApoE and clusterin cooperatively suppress Aβ levels and deposition: evidence that ApoE regulates extracellular Aβ metabolism in vivo Neuron 41, 193-202
21. Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., and Zlokovic, B. V. (2007) Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system J. Cereb. Blood Flow Metab. 27, 909-918
22. Di Paolo, G. and Kim, T. W. (2011) Linking lipids to Alzheimer's disease: cholesterol and beyond Nat. Rev. Neurosci. 12, 284-296
23. Zhang, H., Kim, J. K., Edwards, C. A., Xu, Z., Taichman, R., and Wang, C. Y. (2005) Clusterin inhibits apoptosis by interacting with activated Bax Nat. Cell Biol. 7, 909-915
24. Nuutinen, T., Suuronen, T., Kauppinen, A., and Salminen, A. (2009) Clusterin: a forgotten player in Alzheimer's disease Brain Res. Rev. 61, 89-104
25. Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., Ward, P., and Lieberburg, I. (1992) Complement activation by β-amyloid in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 89, 10016-10020
26. Rostagno, A., Revesz, T., Lashley, T., Tomidokoro, Y., Magnotti, L., Braendgaard, H., Plant, G., Bojsen-Moller, M., Holton, J., Frangione, B., and Ghiso, J. (2002) Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease J. Biol. Chem. 277, 49782-49790
27. Eikelenboom, P. and Stam, F. C. (1982) Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study Acta Neuropathol. 57, 239-242
28. Shibayama, Y., Joseph, K., Nakazawa, Y., Ghebreihiwet, B., Peerschke, E. I., and Kaplan, A. P. (1999) Zinc-dependent activation of the plasma kinin-forming cascade by aggregated β amyloid protein Clin. Immunol. 90, 89-99
29. Owren, P. A. (1947) Parahaemophilia; haemorrhagic diathesis due to absence of a previously unknown clotting factor Lancet 1, 446-448
30. Ahn, H. J., Zamolodchikov, D., Cortes-Canteli, M., Norris, E. H., Glickman, J. F., and Strickland, S. (2010) Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerization Proc. Natl. Acad. Sci. U. S. A. 107, 21812-21817
31. Cortes-Canteli, M., Zamolodchikov, D., Ahn, H. J., Strickland, S., and Norris, E. H. (2012) Fibrinogen and altered hemostasis in Alzheimer's disease J. Alzheimers Dis. 32, 599-608
32. Kivipelto, M., Helkala, E. L., Laakso, M. P., Hanninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., and Nissinen, A. (2001) Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study BMJ [Br. Med. J.] 322, 1447-1451
33. Tristan, C., Shahani, N., Sedlak, T. W., and Sawa, A. (2011) The diverse functions of GAPDH: views from different subcellular compartments Cell Signal 23, 317-323
34. Chuang, D. M., Hough, C., and Senatorov, V. V. (2005) Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases Annu. Rev. Pharmacol. Toxicol. 45, 269-290
35. Oyama, R., Yamamoto, H., and Titani, K. (2000) Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid β-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation Biochim. Biophys. Acta 1479, 91-102
36. Verdier, Y., Foldi, I., Sergeant, N., Fulop, L., Penke, Z., Janaky, T., Szucs, M., and Penke, B. (2008) Characterization of the interaction between Aβ1-42 and glyceraldehyde phosphodehydrogenase J. Pept Sci. 14, 755-762
37. Cumming, R. C. and Schubert, D. (2005) Amyloid-β induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease FASEB J. 19, 2060-2062
38. Wang, Q., Woltjer, R. L., Cimino, P. J., Pan, C., Montine, K. S., Zhang, J., and Montine, T. J. (2005) Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein FASEB J. 19, 869-871
39. van Horssen, J., Otte-Holler, I., David, G., Maat-Schieman, M. L., van den Heuvel, L. P., Wesseling, P., de Waal, R. M., and Verbeek, M. M. (2001) Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains Acta Neuropathol. 102, 604-614
40. Sandwall, E., O'Callaghan, P., Zhang, X., Lindahl, U., Lannfelt, L., and Li, J. P. (2010) Heparan sulfate mediates amyloid-beta internalization and cytotoxicity Glycobiology 20, 533-541
41. Hard, T. and Lendel, C. (2012) Inhibition of amyloid formation J. Mol. Biol. 421, 441-465
42. Palmqvist, S., Zetterberg, H., Blennow, K., Vestberg, S., Andreasson, U., Brooks, D. J., Owenius, R., Hagerstrom, D., Wollmer, P., Minthon, L., and Hansson, O. (2014) Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: A cross-validation study against amyloid positron emission tomography JAMA Neurol. 71, 1282-1289
43. Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., and Minthon, L. (2006) Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurol. 5, 228-234
44. Abelein, A., Bolognesi, B., Dobson, C. M., Graslund, A., and Lendel, C. (2012) Hydrophobicity and conformational change as mechanistic determinants for nonspecific modulators of amyloid β self-assembly Biochemistry 51, 126-137